Research highlights that the loss of genetic material influences the age at which the disorder first appears
Read moreA longitudinal study from the Institut de Recerca Sant Pau (IR Sant Pau), published in Alzheimer’s & Dementia, shows that these alterations can fluctuate and even decrease over time in the Down synd...
Read moreDesarrollan un dispositivo electroquímico que identifica la presencia o ausencia de dopamina y serotonina, dos sustancias químicas clave en el diagnóstico de enfermedades como Alzhéimer, Parkinson...
Read moreLa Comunidad de Madrid inicia este próximo mes de abril un novedoso ensayo clínico en el Instituto de Investigación Sanitaria del Hospital público de La Princesa que abre la puerta al desarrollo d...
Read moreThe LESS-AD study is based on a novel therapeutic hypothesis: administering levetiracetam preventively, before the first epileptic seizure occurs, could not only reduce the risk of seizures but also h...
Read moreHoliAtlas will be especially useful for the study and early diagnosis of neurological and neurodegenerative diseases such as Alzheimer's or Parkinson's
Read moreDesarrollan un hidrogel, biomaterial inteligente que funciona como vehículo de células en la terapia celular para el tratamiento de enfermedades neurológicas caracterizadas por la pérdida de miel...
Read moreEl proyecto STAR-AD, liderado por el Dr. Jordi Duran (IQS) y la Dra. Maite Solas (Universidad de Navarra), investigará cómo el metabolismo de los astrocitos influye en el progreso del Alzheimer.
Read moreCovers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder
Read moreA team from the Spanish National Cancer Research Centre has discovered a novel way in which tumor cells alter the brain to establish themselves and spread cancer.
Read moreCuando se cuida a alguien que vive con demencia, tal vez se observe que, a partir de cierta hora de la tarde, la persona parece “cambiar”. Se muestra más inquieta, pregunta muchas veces lo mismo ...
Read moreA study led by Clínic Barcelona–IDIBAPS shows that continuous lithium treatment significantly reduces the risk of mortality in people with bipolar disorder. The results reinforce the importance of ...
Read more